Log In
Print
BCIQ
Print
Print this Print this
 

Betesil Patch

  Manage Alerts
Collapse Summary General Information
Company Institut Biochimique S.A.
DescriptionSelf-adhesive medicated plaster containing 0.1% betamethasone valerate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Dermatology (unspecified)
Indication DetailsTreat inflammatory skin conditions including plaque psoriasis
Regulatory Designation

Partner

Cipher Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today